Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Recruiting now

Conditions studied: Prostate Cancer

In brief

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Key facts

Study ID

NCT07184957

Run by

NYU Langone Health

People needed

1000

Starts

2017-05-01

Expected to finish

2040-12-31

Last updated by the study team

2026-08-07

Who can join

Age: 40 and older, up to 85. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
• Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

You may not qualify if…

• Men that are not diagnosed with prostate cancer.
• Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

Where it is running

• NYU Langone Health — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.